Xenetic Biosciences Inc - ESG Rating & Company Profile powered by AI
Full ESG analysis of Xenetic Biosciences Inc can be accessed by registering for free. The webpage includes a Q&A table for Xenetic Biosciences Inc. If you work at Xenetic Biosciences Inc and you would like to use your ESG aseessment, please contact us.
Xenetic Biosciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Xenetic Biosciences Inc | 8.0 | High |
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Xenetic Biosciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Xenetic Biosciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Xenetic Biosciences Inc report the average age of the workforce?
Sign up for free to unlockDoes Xenetic Biosciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Xenetic Biosciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Xenetic Biosciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Xenetic Biosciences Inc offer flexible work?
Sign up for free to unlockDoes Xenetic Biosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Xenetic Biosciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Xenetic Biosciences Inc conduct supply chain audits?
Sign up for free to unlockDoes Xenetic Biosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Xenetic Biosciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Xenetic Biosciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Xenetic Biosciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Xenetic Biosciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Xenetic Biosciences Inc disclose water use targets?
Sign up for free to unlockDoes Xenetic Biosciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Xenetic Biosciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes Xenetic Biosciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Xenetic Biosciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Xenetic Biosciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Xenetic Biosciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes Xenetic Biosciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Xenetic Biosciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Xenetic Biosciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Xenetic Biosciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Xenetic Biosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Xenetic Biosciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Xenetic Biosciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Xenetic Biosciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Xenetic Biosciences Inc disclose its waste policy?
Sign up for free to unlockDoes Xenetic Biosciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes Xenetic Biosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Xenetic Biosciences Inc disclose energy use targets?
Sign up for free to unlockDoes Xenetic Biosciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Xenetic Biosciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Xenetic Biosciences Inc
These potential risks are based on the size, segment and geographies of the company.
Xenetic Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, research, and development of next-generation biologic drugs and novel orphan oncology therapeutics. The company's lead investigational product candidate is oncology therapeutic XBIO-101 (sodium cridanimod) for the treatment of progestin resistant endometrial cancer. It is also developing ErepoXen, a drug using PolyXen platform technology for the treatment of anemia in chronic kidney disease patients. The company has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.